HomeOwner SearchCategory Search
Visit USCOStudio controllato sull'impiego de due analoghi nucleosidici piu indinavir in soggetti con infezione da virus dell'immunodeficienza umana e numero delle cellule CDR uguale o inferiore a 200 per millimetro cubo Scott M. Hammer, Kathleen E. Squires, Michael D. Hughes ... [et al.]
Text Registration
Copyright Title
Studio controllato sull'impiego de due analoghi nucleosidici piu indinavir in soggetti con infezione da virus dell'immunodeficienza umana e numero delle cellule CDR uguale o inferiore a 200 per millimetro cubo Scott M. Hammer, Kathleen E. Squires, Michael D. Hughes ... [et al.]
Status
Published
on 14 Jun 2007
Year of Creation
1998
Copyright Claimant
Massachusetts Medical Society (employer for hire)
Registration Number
TX0004771457
on 14 Jun 2007Copyright Summary
The U.S. Copyright record (Registration Number: TX0004771457) dated 14 Jun 2007, pertains to an electronic file (eService) titled "Studio controllato sull'impiego de due analoghi nucleosidici piu indinavir in soggetti con infezione da virus dell'immunodeficienza umana e numero delle cellule CDR uguale o inferiore a 200 per millimetro cubo Scott M. Hammer, Kathleen E. Squires, Michael D. Hughes ... [et al.]" created in 1998. The copyright holder is Massachusetts Medical Society (employer for hire), known for their creative contributions in text registration. For any inquiries concerning this copyrighted material, kindly reach out to Massachusetts Medical Society (employer for hire).
Application Details
Registration Number
TX0004771457
Registration Date
6/14/2007
Year of Creation
1998
Agency Marc Code
DLC-CO
Record Status
New
Corporate Author
Massachusetts Medical Society
Notes
Host Item Entry: New England journal of medicine, Sept. 11, 1997, p. 734-739
Material Matter Claimed Note: New Matter: Italian translation of article
Previous Registration Note: Prev. reg. 1997, TX 4-545-090
© 2024 reserved by Trademarkia
Show terms & conditions
Disclaimer: The information contained in this website is provided for informational purposes only, and should not be construed as legal advice. Although LegalForce RAPC Worldwide P.C., dba Trademarkia P.C., is a law firm (the “Firm”), your use of this website does not establish an attorney-client relationship with the Firm. Such a relationship can only be established after the Firm decides that it is willing and able to accept the engagement after a conflict check and after a written retainer agreement is agreed upon between you and the Firm. Your use of this website is also subject to our Terms of Use and Privacy Policy. ** The entry level subscription is a bundled price which requires a minimum of two billing cycles, or 6 months.